Background {#Sec1}
==========

Inverse treatment planning is now a standard treatment planning method and it normally starts with a template, which aids the specification of the planning objectives. Templates contain population-based experience of the constraints that are suitable for planning the dose delivery to a particular treatment region. The treatment planner sometimes modifies these constraints to account for anatomical variations amongst patients. This modification is based on the planner's subjective judgment of the constraints that are suitable for planning the given anatomy.

Knowledge-based radiation therapy treatment (KBRT) is a technique to objectively incorporate prior experience into radiotherapy treatment planning. KBRT has been proposed as a method of transferring knowledge from the experienced to the less experienced institutions \[[@CR1]\]. Recently, several KBRT approaches \[[@CR2]--[@CR8]\] have been described. Our algorithm \[[@CR2]\] is derived from the analysis of treatment plans optimized by experts. The algorithm relates the dose that is received by the organs-at-risk (OARs) to their geometric proximity to the treated volume, and thus provides a method to objectively incorporate individual patient anatomical variations in the treatment planning and acceptance process. Unlike the other approaches, the algorithm can predict the 3D dose distribution in the organs of interest.

The likelihood of radiation therapy treatment planning becoming fully automated in the next ten years was recently debated \[[@CR9]\]. The opponent of this proposition conceded that KBRT and/or computer-aided multicriterial optimization would be widely employed to eliminate the present-day human variability from the treatment plan optimization process \[[@CR9]\]. But before KBRT can be confidently adopted as a clinical tool, whether to aid or to replace the experienced planner as argued in the cited work, it is necessary to compare the quality of plans that are generated with the KBRT approach against those that are made by experienced planners.

Therefore, the purpose of this study is to evaluate how this objective approach compares to the subjective judgment of the experienced treatment planner in terms of treatment plan quality. A novice planner with no previous treatment planning experience was given the anatomical data of 30 subjects that were treated for prostate cancer in our institution. The inexperienced planner utilized the KBRT algorithm to predict the probable dose of the OARs based on their proximity to the target volume. The predicted information was thereafter used to modify the reference constraints and a plan was subsequently generated. These plans were compared to the reference plans that were made by experienced planners.

Methods {#Sec2}
=======

Ethics approval and patient selection {#Sec3}
-------------------------------------

This study was approved by the Medical Ethics Commission of the Medical Faculty Mannheim, Heidelberg University. Thirty volumetric modulated arc therapy (VMAT) plans were randomly selected from a database of patients that were treated for prostate cancer at the University Medical Centre, Mannheim. These *expert plans* were created by experienced planners. An inexperienced planner, aided by a KBRT algorithm \[[@CR2]\] generated a second set of *KBRT plans* for the 30 subjects. All the plans were made with the *MONACO®* treatment planning system (CMS, Elekta, Crawley, UK). The following sections detail how these plans were generated.

### Expert plans {#Sec4}

The expert plans were created by experienced planners and were approved by a physician and a physicist for patient treatment. We define an experienced planner as personnel who is knowledgeable in treatment planning by virtue of a good understanding of the treatment planning system and the planning constraints that are suitable/applicable for planning a given treatment site. The making of these plans began with a template to aid the specification of the planning constraints. Experienced planners created the templates that are used in our institution. A template, which is used for prostate cancer planning in our institution, is shown in Table [1](#Tab1){ref-type="table"}. The planner sometimes modifies these reference constraints (for the dose to the structures of interest). For example, a planner may reduce or increase the reference (template-specified) dose to the bladder based on the fraction of this organ that is included in the planning target volume (PTV). If the initial plan that is generated (with or without the modification of the reference constraints) is deemed to be of poor quality, the planning constraints are further adjusted and the case is replanned. This process is repeated until a plan is generated which is acceptable to both the responsible physician and physicist. This iterative process is both time-consuming and labor intensive.Table 1A MONACO® planning template for prostate VMAT at the Universitätsmedizin Mannheim. P + SB = prostate and seminal vesiclesStructureCost functionReference dose (cGy)IsoconstraintP + SBTarget EUD6000.0Quadratic overdose6000.070.0Quadratic underdose6000.070.0BladderParallel3000.040.0Serial3500.0RectumParallel3000.030.0Quadratic overdose3000.050.0PatientQuadratic overdose3500.0120.0Quadratic overdose2200.060.0Conformality0.7

### KBRT plans {#Sec5}

The KBRT algorithm and planning CT (the input to the algorithm) were given to a novice with no prior treatment planning experience. The inexperienced planner used the algorithm to predict the likely dose to the OARs (rectum and bladder) based on their proximity to the PTV \[[@CR2]\]. Dose-volume constraints extracted from the predicted 3D dose distribution were used to modify the reference constraints of the template and a KBRT plan was subsequently generated. Hence, all other planning parameters (i.e. beam arrangement and dose calculation properties) were the same for the KBRT and expert plans.

### Comparison of the quality of the KBRT and expert plans {#Sec6}

Both sets of plans were compared for the achieved target coverage and normal tissue sparing. The uniformity index (UI) provided a quantitative measure of the target coverage. The UI is defined as the ratio of D~05~ and D~95~$$\documentclass[12pt]{minimal}
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                \begin{document}$$ UI=\frac{D_{05}}{D_{95}} $$\end{document}$$where D~05~ and D~95~ are the maximum doses that cover at least 5 % and 95 % of the target volumes respectively. UI values closer to 1 indicate better homogeneity, while larger values imply increasing heterogeneity \[[@CR10], [@CR11]\]. To compare the planned doses to the OARs, five dose-volume points (D~x~ = D~90~, D~70,~ D~50~, D~30~ and D~10~) were used, where D is the maximum dose that is received by x % volume of the organ. The dose difference DD~*x*~, between the individual D~*x*~ values of the KBRT and expert plans were also calculated according to$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ D{D}_x={D}_x^{KBRT}-{D}_x^{Expert} $$\end{document}$$

### Statistical analysis {#Sec7}

Mean values and standard deviations were calculated for descriptive statistics. Wilcoxon matched-pairs signed rank tests were performed using GraphPad Prism (version 6.05 for Windows, GraphPad Software, La Jolla California USA, [www.graphpad.com](http://www.graphpad.com)). P values lower than 0.05 were considered to denote statistically significant differences between the compared datasets.

Results {#Sec8}
=======

Target coverage {#Sec9}
---------------

The KBRT plans achieved an average Uniformity Index (UI) of 1.10 ± 0.04, while the expert plans achieved an average UI of 1.10 ± 0.03. The Wilcoxon test showed no significant difference between the D~05~, D~95~ and UI values of the two groups of plans, implying that both sets of plans achieved similar coverage of the PTV.

OAR sparing {#Sec10}
-----------

Figures [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"} and Table [2](#Tab2){ref-type="table"} compare the planned dose to the bladder and rectum for the two approaches. Five dose-volume levels (D~10~, D~30,~ D~50~, D~70~ and D~90~) are used for the comparison. All values are normalized to the prescribed dose of the target volume. Table [2](#Tab2){ref-type="table"} provides a quantitative summary (average values and their standard deviations) of the results.Fig. 1Bladder dose of the KBRT and expert plans. The central line of each box shows the median value, while the upper and lower edges represent the 25^th^ (Q1) and 75^th^ (Q3) percentiles respectively. The whiskers extend to values that are not considered as outliers (approximately mean ± 2.7 times standard deviation for normally distributed data). The individual pluses (+) are the extreme values that are considered as outliers. The Wilcoxon test shows that the KBRT plans achieved significantly lower dose to the bladder (at D~30~) when compared to the expert plansFig. 2Rectal dose of the KBRT and expert plans. The Wilcoxon test results showed that the expert plans achieved significantly lower dose to the rectum (at D~30~ and D~10~) when compared to the KBRT plansTable 2Summary of the organ doses (mean ± standard deviation) of the KBRT and expert plans. All doses are normalized to dose that is prescribed to the target volume. The Wilcoxon test shows significantly lower bladder dose for the KBRT plans (at D~30~), as well as lower rectal dose (at D~10~ and D~30~) for the expert plansOrgan volume \[%\]BladderRectumMean organ dose of KBRT plans \[%\]Mean organ dose of expert plans \[%\]Mean organ dose difference (KBRT - expert)Mean organ dose of KBRT plans \[%\]Mean organ dose of expert plans \[%\]Mean organ dose difference (KBRT- expert)1098.4 ± 4.498.3 ± 5.00.1 ± 2.993.0 ± 7.990.1 ± 9.53.0 ± 4.53070 ± 2574 ± 22−3.0 ± 6.363 ± 1757 ± 165.6 ± 8.15044 ± 3046 ± 29−2.7 ± 9.139 ± 1336.8 ± 9.92.4 ± 7.57024 ± 2224 ± 190.0 ± 7.124.6 ± 9.024.8 ± 7.1−0.3 ± 5.49011 ± 129.8 ± 8.71.0 ± 6.211.9 ± 6.212.6 ± 6.8−0.7 ± 3.4

Figure [1](#Fig1){ref-type="fig"} shows the planned dose to bladder of the KBRT and expert plans. The KBRT plans achieved a marginally lower dose to the bladder compared to the expert plans.

Figure [2](#Fig2){ref-type="fig"} compares the planned dose to rectum of the KBRT and expert plans. The expert plans achieved lower rectal dose compared to the KBRT plans.

Discussion {#Sec11}
==========

In this work the treatment plan qualities of two sets of plans that are generated by an experienced planner and a novice are investigated. The novice planner was guided by a knowledge-based radiation therapy (KBRT) treatment planning algorithm \[[@CR2]\]. The results show that both sets of plans achieved similar target coverage. The KBRT approach achieved an overall statistically significant lower bladder dose compared to the expert plans, while the expert plans achieved a statistically significant lower rectal dose compared to the KBRT plans.

Considering the magnitude of the difference between the mean OAR doses (Table [2](#Tab2){ref-type="table"}), it can be argued that the expert plans are superior. However, this is not a statement of inferiority of the objective approach, but may be suggestive of the need to improve the organ model of the rectum in the KBRT algorithm. The model can be improved for example through the careful selection of the data that are included in the learning database as discussed in the previous publication \[[@CR2]\]. Although the Wilcoxon test show statistically significant differences in the OAR doses of the two approaches, it is unclear if these differences are clinically relevant.

Earlier studies suggest that KBRT plans are non-inferior to those that are made by experienced planners \[[@CR12], [@CR1]\]. Even if marginally inferior to the subjective approach, the objective KBRT approaches offer some advantages over the subjective approach (lower number of replans, less dependence on the experience of the planner, reduced planning time, etc.). This study thus shows that KBRT planning is capable of reducing inter-personnel variability of treatment plan quality \[[@CR9]\] and also demonstrates that the influence of the experience of the planner can be minimized with the aid of an optimized KBRT algorithm. A prototype of the algorithm for clinical use is planned in the future after further validation of the algorithm for other treatment sites.

Conclusion {#Sec12}
==========

A KBRT algorithm for the prostate was validated using treatment plans of 30 patients with prostate carcinoma. The results of our study suggest that KBRT treatment planning based on our published algorithm is a valid method to objectively include individual patient anatomical information in the treatment planning process. The results show that treatment plan quality achieved with the KBRT approach is comparable to the plan quality of the experienced planners.
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